Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
Public ClinicalTrials.gov record NCT00507455. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multi-Center Study to Evaluate the Safety of the Co-administration of Solifenacin Succinate With 0.4 mg Tamsulosin Hydrochloride OCAS (TOCAS) Using Urodynamics in Male Subjects With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Study identification
- NCT ID
- NCT00507455
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Enrollment
- 222 participants
Conditions and interventions
Interventions
- Placebo to solifenacin Drug
- Placebo to tamsulosin Drug
- solifenacin succinate Drug
- tamsulosin hydrochloride Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2007
- Primary completion
- Jul 31, 2008
- Completion
- Jul 31, 2008
- Last update posted
- Aug 5, 2014
2007 – 2008
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Homewood | Alabama | 35209 | — |
| Not listed | La Mesa | California | 91942 | — |
| Not listed | Long Beach | California | 90806 | — |
| Not listed | San Bernardino | California | 92404 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | Middlebury | Connecticut | 06762 | — |
| Not listed | New Port Richey | Florida | 34655 | — |
| Not listed | Coeur d'Alene | Idaho | 83814 | — |
| Not listed | Des Moines | Iowa | 50309 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Watertown | Massachusetts | 02472 | — |
| Not listed | Las Vegas | Nevada | 89148 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | Greensboro | North Carolina | 27403 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00507455, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2014 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00507455 live on ClinicalTrials.gov.